The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.” But before the 60-second spot was ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...
Morgan Stanley analyst Craig Hettenbach downgraded Hims & Hers to Equal Weight from Overweight with a price target of $60, up from $42. The ...
Hims & Hers makes its Super Bowl commercial debut ... Glover), the commercial calls out weight loss prescriptions and the ...
telehealth company Hims & Hers on Jan. 28 released a provocative commercial attacking the weight loss industry to get attention. And it’s done just that: Lawmakers now want the Food and Drug ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results